Journal
FRONTIERS IN MEDICINE
Volume 9, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2022.1014257
Keywords
immune checkpoint inhibitors; immune-related adverse events; nephrotoxicity; ICI-induced acute kidney injury; multidisciplinary management
Categories
Ask authors/readers for more resources
This review summarizes the current knowledge of immune checkpoint inhibitors (ICIs)-induced nephrotoxicity, emphasizing the underestimated difficulty in diagnosis and discussing the treatment options and future research directions.
Although immune checkpoint inhibitors (ICIs) have dramatically revolutionized the field of oncology over the last decade, severe immune-related adverse events (irAEs) are potentially life-threatening. In comparison with toxicities involving the skin, gastrointestinal tract and endocrine system, nephrotoxicity is less common but often underestimated due to difficult diagnosis. Management usually consists of treatment discontinuation and/or corticosteroid use. In this review, we summarize current knowledge of ICI-induced nephrotoxicity, evaluating drawbacks and future perspectives.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available